Grants for Independent school districts - Health

This grant provides funding for short courses that aim to enhance research skills in using cognitive data to study aging and Alzheimer's disease across different countries, ultimately improving health outcomes and informing policies.

The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative, transdisciplinary, translational research projects which advance exceptionally promising, chemically complex botanical and other natural products relevant to dietary supplements towards highly informative clinical trials of their effects on quantitative, objective measures of human resilience. Dynamic, synergistic interactions among the range of experts required to ensure rigor in all aspects of this research will be supported by a multi-PD/PI team collaborating on a single set of integrated specific aims, culminating in data on optimal parameters for a future proposed clinical efficacy trial, as well as the development and validation of other critical knowledge and methods for interpretation of such a trial, such as clinical assessment of the engagement of an outcome-relevant target. Enhancing workforce and institutional capacity to conduct future rigorous, transdisciplinary research on chemically complex natural products must be built into the plans for research and for enhancing diverse perspectives. Achievement of the RM1 specific aims is expected to provide a strong foundation for a future highly informative clinical efficacy trial of the effects on resilience of a chemically complex natural product.This NOFO is one component of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include RFA-AT-24-008, Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01) and RFA-AT-24-007, Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).

The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal of advancing therapeutic opportunities, and/or 3) validates association data in order to improve the predictive power of clinical disease screening.

This funding opportunity is designed to strengthen health informatics capabilities in PEPFAR-supported countries by developing a skilled workforce and enhancing digital health systems to combat HIV/AIDS and tuberculosis effectively.

This funding opportunity supports higher education institutions, nonprofit organizations, for-profit organizations, and local governments in establishing a Coordinating Center to implement and evaluate population genomic screening in primary care, focusing on diverse communities and actionable genetic conditions.

This funding opportunity provides financial support to organizations in Ohio looking to establish new Child Advocacy Centers that focus on preventing child abuse and neglect through collaborative, child-friendly services.

This funding opportunity is designed for U.S. academic institutions with specialized mining programs to develop innovative technologies and research that improve the safety and effectiveness of underground mine evacuations during emergencies.

This funding opportunity supports U.S. institutions conducting clinical trials on innovative regenerative medicine therapies using adult stem cells, focusing on extending research from previously funded projects.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for large single or multisite clinical trials within the mission area of the institute. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New, Resubmission and Revision applications will be eligible. This NOFO will utilize the UG3/UH3 phased cooperative agreement activity code. A UG3 milestone plan is required. Details of the planned NOFO are provided below.

This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds , including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA (see RFA-HL-22-010).

This funding opportunity supports research projects that develop and implement community-focused interventions to improve vision health outcomes and address disparities among underserved populations.

This grant opportunity allows Skilled Nursing Facilities to apply for funding to purchase tablets and tablet-related accessories. Facilities must attest the tablets will be used for facilitating virtual telehealth or family visits for residents. Facilities must be certified through the Centers of Medicare and Medicaid Services (CMS). Applicants may generally request up to $3,000.00, however requests beyond $3,000.00 will be accepted and will require CDPH and CMS review. Applicants must use the template provided on the CDPH website; cover letters are not required. Keywords: Tablet, Communicative Technology, Skilled Nursing Facility, CMS, CDPH, CMP, Civil Money Penalty, Public Health, SNF

The Artistic Legacy Grant (ALG), funded by the San Francisco Arts Commission, offers $10,000 to $100,000 for a 3-year period to support and celebrate an artist who has significantly contributed to San Francisco's arts and culture for at least 25 years, with funds to be used for professional development, artistic planning, sabbaticals, and other related costs.

The grant titled "Mechanistic Investigations into ADRD Associated Protein Structures in Biological Settings" aims to use recent advancements in structural biology to study protein assemblies related to Alzheimer's disease and related dementias (AD/ADRD) in their natural environments within cells and tissues, with the goal of developing ligands that can identify and monitor these proteins in patients.

This funding opportunity supports the development of innovative computational tools to enhance the use of the human pangenome in genomic research, particularly for applications in cancer, aging, and diverse populations.

The purpose of this Funding Opportunity Announcement (FOA) is to diversify the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This initiative will emphasize the development of skills in data science and drug discovery, and their application to various aspects of AD/ADRD research (from populations studies to research that can lead to new treatments and diagnostics, including all aspects of behavioral and social research). This initiative will support early career, independent investigators from diverse backgrounds to gain critical translational skills in data science and drug discovery. The long-term goal of this program is to develop a diverse translational workforce that can effectively participate in and/or lead a team-science, precision medicine approach to AD/ADRD treatment, prevention, early detection, and disease management and care.

This funding opportunity supports Arizona-based institutions conducting clinical research on ibogaine to treat neurological diseases, aiming to advance health and wellness for residents through innovative, collaborative projects.

This grant provides funding for research projects that implement screening and intervention strategies for alcohol, tobacco, and drug use among adult populations facing health disparities, such as racial minorities and low-income communities.

This funding opportunity supports researchers developing innovative technologies to enhance the delivery of treatments for HIV and substance use disorders, focusing on improving patient outcomes and understanding the effects of addictive substances.

This funding opportunity provides small grants to early-career researchers who have received specific NHLBI K awards, allowing them to expand their research projects or explore new studies that build on their previous work.